The rise of a grey market in India, where unsupervised doses are sold at exorbitant rates, demonstrates that excessive control merely drives patients underground. Regulation should protect safety, not ...

There are two contrasting opinions about Russia’s pharmaceutical market. A common sight on Russian-speaking forums across ...